Paper16639716
Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.
Rodgers T and 1 other. J Pharm Sci, 2006. Cited by 781 papers, by iCite.
Cite this record
ConductScience Library. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. Papers, record 16639716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16639716
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Models, Biological | Major topic |
| Pharmacokinetics | Major topic |
| Animals | |
| Blood Proteins | |
| Body Fluid Compartments | |
| Computer Simulation | |
| Erythrocytes | |
| Octanols | |
| Phospholipids | |
| Predictive Value of Tests | |
| Quantitative Structure-Activity Relationship | |
| Rats | |
| Tissue Distribution | |
| Water |
Source PubMed
Cited by433
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 781 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942743 | PBPK Modeling of CES1-Activated Prodrugs Across Different Age Groups: Simultaneous Prodrug-Metabolite Prediction for Oseltamivir, Enalapril, and Cilazapril. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942743 | PubMed |
| 42872351 | Mechanistic Prediction of Maternal, Fetal, and Amniotic Fluid Betamethasone Concentrations to Support Dosing Optimization in Pregnancy. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42872351 | PubMed |
| 42864476 | Development of a Mechanistic Distribution Model for Predicting Drug Partitioning into Human Milk. | Pharm Res | 2026 | https://conductscience.org/library/papers/42864476 | PubMed |
| 42806801 | Physiologically Based Pharmacokinetic Modeling to Characterize the Disposition of Topiramate in Children with and without Obesity. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42806801 | PubMed |
| 42789173 | Formalizing method choice: a data-driven selection of mechanistic models for predicting human heart drug partitioning. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/42789173 | PubMed |
| 42682186 | A Practical Alternative to Refine the Estimate of fmCYP3A4 and Evaluate Drug-Drug Interaction Potential for Ziftomenib Using PBPK Modeling to Inform Labeling. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42682186 | PubMed |
| 42582297 | Coproporphyrin I PBPK model in the open systems pharmacology suite enables precise prediction of OATP 1B- mediated drug interactions through calibrated In vivo inhibition constants. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42582297 | PubMed |
| 42571641 | A Systematic Review of Published Physiologically Based Pharmacokinetic Models for Drug Excretion Into Human Breastmilk: Knowledge Gaps and Opportunities to Optimize Reporting and Modeling Practices. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42571641 | PubMed |
| 42528013 | Sex-Related Differences in Physiologically-Based Biopharmaceutics Modeling. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42528013 | PubMed |
| 42418317 | Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK, High-Throughput PBPK, and Machine Learning. | Mol Pharm | 2026 | https://conductscience.org/library/papers/42418317 | PubMed |
| 42363979 | PBK modelling of phthalates and their metabolites and the application in next generation risk assessment. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42363979 | PubMed |
| 42353261 | Complex Distribution Phenomena and Plastic Binding of Test Chemicals in Cell Culture Experiments: Exemplification by Tebufenpyrad. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353261 | PubMed |
| 42312170 | Age-Driven Physiologically Based Pharmacokinetic Modeling of Empagliflozin: Toward Precision Dosing in Youth. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42312170 | PubMed |
| 42297946 | Model-informed dose optimization of carvedilol and nebivolol in cirrhotic patients: a pilot randomized clinical study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42297946 | PubMed |
| 42251051 | Prediction variability in physiologically based pharmacokinetic modeling of tissue disposition under deep uncertainty. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/42251051 | PubMed |
| 42232789 | Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach. | Front Tuberc | 2026 | https://conductscience.org/library/papers/42232789 | PubMed |
| 42185666 | Integrated human toxicokinetics of acetamiprid using urine, blood, and feces data in physiologically-based kinetic modelling for reverse dosimetry. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42185666 | PubMed |
| 42183848 | Applicability of next-generation risk assessment generic PBK models and their performance within the chemical domain. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42183848 | PubMed |
| 42067648 | Implementation of growth curves in a generic physiologically based kinetic model with a case study of perfluorooctanesulfonic acid (PFOS) in beef cattle, sheep, and chicken. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42067648 | PubMed |
| 41951999 | Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis. | AAPS J | 2026 | https://conductscience.org/library/papers/41951999 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16639716
GET https://conductscience.org/api/papers/v1/16639716/cited_by?page=2